[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Artivion Inc (AORT)

Artivion Inc (AORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,289,787
  • Shares Outstanding, K 48,543
  • Annual Sales, $ 441,330 K
  • Annual Income, $ 9,770 K
  • EBIT $ 37 M
  • EBITDA $ 60 M
  • 60-Month Beta 1.25
  • Price/Sales 2.88
  • Price/Cash Flow 23.75
  • Price/Book 2.82

Options Overview Details

View History
  • Implied Volatility 57.54% (-11.00%)
  • Historical Volatility 44.02%
  • IV Percentile 27%
  • IV Rank 7.67%
  • IV High 343.80% on 11/28/25
  • IV Low 33.76% on 08/12/25
  • Expected Move (DTE 14) 0.17 (0.63%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 14
  • Volume Avg (30-Day) 75
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 670
  • Open Int (30-Day) 484
  • Expected Range 26.95 to 27.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.13
  • Number of Estimates 1
  • High Estimate $0.13
  • Low Estimate $0.13
  • Prior Year $0.16
  • Growth Rate Est. (year over year) -18.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.83 +18.79%
on 07/14/26
28.29 -4.14%
on 08/03/26
+2.66 (+10.87%)
since 07/07/26
3-Month
19.16 +41.54%
on 05/08/26
28.29 -4.14%
on 08/03/26
-8.30 (-23.43%)
since 05/07/26
52-Week
19.16 +41.54%
on 05/08/26
48.25 -43.79%
on 12/17/25
-5.58 (-17.06%)
since 08/07/25

Most Recent Stories

More News
Artivion: Q2 Earnings Snapshot

Artivion: Q2 Earnings Snapshot

AORT : 27.12 (+2.07%)
Artivion (NYSE:AORT) Delivers Strong Q2 CY2026 Numbers

Artivion (NYSE:AORT) Delivers Strong Q2 CY2026 Numbers

AORT : 27.12 (+2.07%)
Artivion Reports Second Quarter 2026 Financial Results

Second Quarter & Recent Business Highlights:

AORT : 27.12 (+2.07%)
Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect

Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect

AORT : 27.12 (+2.07%)
3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals

NEO : 16.57 (+6.49%)
AORT : 27.12 (+2.07%)
OCUL : 9.19 (+5.15%)
3 Small-Cap Stocks We Keep Off Our Radar

3 Small-Cap Stocks We Keep Off Our Radar

OPAD : 4.79 (+5.74%)
UPLD : 5.25 (+22.66%)
AORT : 27.12 (+2.07%)
Artivion to Participate in Upcoming Investor Conferences

ATLANTA , July 28, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming...

AORT : 27.12 (+2.07%)
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results

ATLANTA , July 23, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT),  a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2026 financial...

AORT : 27.12 (+2.07%)
3 Reasons to Sell AORT and 1 Stock to Buy Instead

3 Reasons to Sell AORT and 1 Stock to Buy Instead

AORT : 27.12 (+2.07%)
3 Stocks Under $50 with Warning Signs

3 Stocks Under $50 with Warning Signs

IP : 41.58 (+2.59%)
SGRY : 15.53 (+4.09%)
AORT : 27.12 (+2.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants....

See More

Key Turning Points

3rd Resistance Point 29.55
2nd Resistance Point 28.91
1st Resistance Point 28.01
Last Price 27.12
1st Support Level 26.48
2nd Support Level 25.83
3rd Support Level 24.94

See More

52-Week High 48.25
Fibonacci 61.8% 37.14
Fibonacci 50% 33.71
Fibonacci 38.2% 30.27
Last Price 27.12
52-Week Low 19.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.